Dr. Reddy's Laboratories Limited RDY
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 106.24% | 95.06% | -82.29% | -17.48% | -0.65% |
| Total Depreciation and Amortization | -3.01% | -6.74% | 4.15% | 1.15% | 3.90% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -41.91% | 93.77% | -64.30% | 230.44% | -132.69% |
| Change in Net Operating Assets | 17.77% | -260.48% | 186.71% | -211.57% | 69.41% |
| Cash from Operations | 663.64% | -105.74% | 39.65% | -31.35% | 4.35% |
| Capital Expenditure | 30.73% | 26.92% | 34.09% | -25.79% | 25.38% |
| Sale of Property, Plant, and Equipment | 79.71% | 119.50% | 1,428.05% | -91.09% | 236.99% |
| Cash Acquisitions | 100.00% | 93.24% | -- | -- | -- |
| Divestitures | -100.00% | -- | -- | -- | -- |
| Other Investing Activities | -16.24% | 136.37% | -412.89% | 20.40% | 64.88% |
| Cash from Investing | 10.30% | 114.02% | -150.57% | -5.70% | 51.26% |
| Total Debt Issued | -- | -- | -4.01% | 244.38% | 3,621.43% |
| Total Debt Repaid | 104.50% | -1,316.30% | -42.71% | -20.50% | 26.69% |
| Issuance of Common Stock | -72.58% | 213.92% | 163.33% | -67.39% | -53.06% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | 100.00% | -- |
| Other Financing Activities | 20.01% | -24.52% | -32.48% | 16.58% | 1.84% |
| Cash from Financing | -5.16% | -197.88% | -11.87% | 243.18% | -333.72% |
| Foreign Exchange rate Adjustments | -107.61% | -92.64% | 39.52% | 79.92% | 7.99% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 147.22% | -22.71% | -136.59% | 850.80% | 115.82% |